PrEP works when used properly. So why don’t women use it?
In the months since the FDA’s approval of Truvada, some who work on prevention efforts in Black and low-income communities have urged PrEP proponents to pump their brakes.
A New York Times article looks at how parents do (and should) react when their children inevitably see Internet pornography, an FDA advisory panel recommends approving a drug for HIV-prevention, and Massachusetts cuts over $1 million from its HIV-prevention and testing program in county jails.
In this week’s sexual health roundup: scientists use engineered stem-cells to attack HIV; California tests a new pill that prevents HIV infection when taken daily but some question how expensive it is; the CDC releases alarming data on cancers caused by HPV in women; and South Carolina lawmakers take steps to increase HPV vaccination among middle school students.
